UPLOAD Filing
Opus Genetics, Inc.
Date: March 17, 2026 · CIK: 0001228627 · Accession: 0000000000-26-002709
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294295
Letter
March 17, 2026 George Magrath Chief Executive Officer Opus Genetics, Inc. 8 Davis Drive, Suite 220 Durham, NC 27713 Re:Opus Genetics, Inc. Registration Statement on Form S-3 Filed March 13, 2026 File No. 333-294295 Dear George Magrath: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Istvan A. Hajdu, Esq.
Show Raw Text
March 17, 2026
George Magrath
Chief Executive Officer
Opus Genetics, Inc.
8 Davis Drive, Suite 220
Durham, NC 27713
Re:Opus Genetics, Inc.
Registration Statement on Form S-3
Filed March 13, 2026
File No. 333-294295
Dear George Magrath:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Istvan A. Hajdu, Esq.